Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Liver abscess following transarterial chemoembolization.

Cheng D.

Semin Intervent Radiol. 2011 Dec;28(4):450-6. doi: 10.1055/s-0031-1296088. No abstract available.

2.

A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma.

Shin JU, Kim KM, Shin SW, Min SY, Park SU, Sinn DH, Gwak GY, Choi MS, Lee JH, Paik SW, Yoo BC, Koh KC.

Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2.

PMID:
24881853
3.

Liver abscess formation after transarterial chemoembolization for malignant hepatic tumor.

Huang SF, Ko CW, Chang CS, Chen GH.

Hepatogastroenterology. 2003 Jul-Aug;50(52):1115-8.

PMID:
12845993
4.

Hepatic abscess complicating transarterial chemoembolization in a patient with liver metastases.

Johnson GE, Ingraham CR, Nair AV, Padia SA.

Semin Intervent Radiol. 2011 Jun;28(2):193-7. doi: 10.1055/s-0031-1280663.

6.

Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: a meta-analysis.

Si T, Chen Y, Ma D, Gong X, Guan R, Shen B, Peng C.

J Gastroenterol Hepatol. 2017 Jan 13. doi: 10.1111/jgh.13727. [Epub ahead of print]

PMID:
28085213
7.

Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases.

Makary MS, Kapke J, Yildiz V, Pan X, Dowell JD.

J Vasc Interv Radiol. 2016 Sep;27(9):1298-304. doi: 10.1016/j.jvir.2016.05.014. Epub 2016 Aug 4.

PMID:
27499157
8.

Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?

Kohi MP, Fidelman N, Naeger DM, LaBerge JM, Gordon RL, Kerlan RK Jr.

J Vasc Interv Radiol. 2013 Jan;24(1):68-73. doi: 10.1016/j.jvir.2012.08.032. Epub 2012 Nov 22.

9.

Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.

Miura JT, Gamblin TC.

Surg Oncol Clin N Am. 2015 Jan;24(1):149-66. doi: 10.1016/j.soc.2014.09.004. Epub 2014 Oct 7. Review.

PMID:
25444473
10.

Arterial portography during transarterial chemoembolization: still a necessity in the age of contrast-enhanced cross-sectional imaging?

Hui TC, Pua U.

J Vasc Interv Radiol. 2014 Jan;25(1):41-6. doi: 10.1016/j.jvir.2013.10.014. Epub 2013 Nov 26.

PMID:
24290098
11.

Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors.

Woo S, Chung JW, Hur S, Joo SM, Kim HC, Jae HJ, Park JH.

AJR Am J Roentgenol. 2013 Jun;200(6):1370-7. doi: 10.2214/AJR.12.9630.

PMID:
23701078
12.

[Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].

Kim MH, Choi MS, Choi YS, Kim DY, Lee JM, Paik SW, Lee JH, Koh KC, Yoo BC, Choi D, Rhee JC.

Korean J Hepatol. 2006 Mar;12(1):55-64. Korean.

13.

Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.

Prajapati HJ, Dhanasekaran R, El-Rayes BF, Kauh JS, Maithel SK, Chen Z, Kim HS.

J Vasc Interv Radiol. 2013 Mar;24(3):307-15. doi: 10.1016/j.jvir.2012.11.026. Epub 2013 Jan 29.

PMID:
23375519
14.

[Hepatogastric fistula after chemoembolization of liver metastasis: a case report].

Leite AK, Koszka AJ, Portieri R, Bittencourt MV, Karakhanian WK, Ribeiro MA, Valentino W, da Silva JF, David AI.

Acta Gastroenterol Latinoam. 2012 Mar;42(1):59-63. Portuguese.

PMID:
22616501
15.

Hepatic abscess with biliary communication following transarterial chemoembolization of hepatocellular carcinoma.

Huang RJ, Ambrosy AP, Triadafilopoulos G.

Dig Dis Sci. 2013 Sep;58(9):2463-5. doi: 10.1007/s10620-013-2593-1. Epub 2013 Feb 20. No abstract available.

PMID:
23423503
16.

Serum microRNA-210 as a predictive biomarker for treatment response and prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Zhan M, Li Y, Hu B, He X, Huang J, Zhao Y, Fu S, Lu L.

J Vasc Interv Radiol. 2014 Aug;25(8):1279-1287.e1. doi: 10.1016/j.jvir.2014.04.013. Epub 2014 Jun 13.

PMID:
24935355
17.

Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.

Rostambeigi N, Dekarske AS, Austin EE, Golzarian J, Cressman EN.

J Vasc Interv Radiol. 2014 Jul;25(7):1075-84. doi: 10.1016/j.jvir.2014.04.014. Epub 2014 May 24. Review.

PMID:
24861664
18.

Noncontrast chest computed tomography immediately after transarterial chemoembolization in patients with hepatocellular carcinoma: clinical benefits and effect of radiation reduction on image quality in low-dose scanning.

Choi JI, Kim HB, Kim MJ, Lee JS, Koh YW, An SB, Ko HK, Park JW.

Eur J Radiol. 2011 Nov;80(2):e188-94. doi: 10.1016/j.ejrad.2011.06.009. Epub 2011 Jun 25.

PMID:
21708441
19.

Intratumoral gas in hepatocellular carcinoma following transarterial chemoembolization: associated factors and clinical impact.

Bisseret D, Ronot M, Abdel-Rehim M, Sibert A, Bouattour M, Castera L, Belghiti J, Vilgrain V.

J Vasc Interv Radiol. 2013 Nov;24(11):1623-31. doi: 10.1016/j.jvir.2013.07.021. Epub 2013 Sep 12.

PMID:
24035417
20.

Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.

Xue T, Le F, Chen R, Xie X, Zhang L, Ge N, Chen Y, Wang Y, Zhang B, Ye S, Ren Z.

Med Oncol. 2015 Mar;32(3):64. doi: 10.1007/s12032-015-0504-3. Epub 2015 Feb 15.

PMID:
25682389

Supplemental Content

Support Center